Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines
- PMID: 10721008
- DOI: 10.1046/j.1525-1373.2000.22354.x
Clonal heterogeneity in telomerase activity and telomere length in tumor-derived cell lines
Abstract
The ribonucleoprotein, telomerase, is responsible for the maintenance of telomere length in most immortal and cancer cells. Telomerase appears to be a marker of human malignancy with at least 85% of human cancers expressing its activity. In the present study, we examined a series of tumor-derived and in vitro immortalized cell lines for telomerase activity levels, telomere lengths, and expression levels of the RNA and catalytic components of telomerase. We found significant variability in both telomere lengths and telomerase activity in clones from tumor cells. In addition, the levels of telomerase components or telomerase activity were not predictive of telomere length. Data from clonally derived cells suggest that critically shortened telomeres in these tumor-derived cell lines may signal activation of telomerase activity through an increase in the expression of the catalytic subunit of telomerase. Although clones with low telomerase shorten their telomeres over time, their subclones all have high levels of telomerase activity with no telomere shortening. In addition, analysis of early clones for telomerase activity indicates substantial variability, which suggests that activity levels fluctuate in individual cells. Our data imply that cell populations exhibit a cyclic expression of telomerase activity, which may be partially regulated by telomere shortening.
Similar articles
-
Telomere length dynamics in telomerase-positive immortal human cell populations.Exp Cell Res. 1998 Mar 15;239(2):370-8. doi: 10.1006/excr.1997.3907. Exp Cell Res. 1998. PMID: 9521855
-
Immortal, telomerase-negative cell lines derived from a Li-Fraumeni syndrome patient exhibit telomere length variability and chromosomal and minisatellite instabilities.Carcinogenesis. 2003 May;24(5):953-65. doi: 10.1093/carcin/bgg024. Carcinogenesis. 2003. PMID: 12771041
-
Telomere dynamics in cells with introduced telomerase: a rapid assay for telomerase activity on telomeres.Mol Cell Biol Res Commun. 2000 May;3(5):312-8. doi: 10.1006/mcbr.2000.0229. Mol Cell Biol Res Commun. 2000. PMID: 10964756
-
Immortalized cells with no detectable telomerase activity. A review.Biochemistry (Mosc). 1997 Nov;62(11):1254-62. Biochemistry (Mosc). 1997. PMID: 9467849 Review.
-
Tissue formation and tissue engineering through host cell recruitment or a potential injectable cell-based biocomposite with replicative potential: Molecular mechanisms controlling cellular senescence and the involvement of controlled transient telomerase activation therapies.J Biomed Mater Res A. 2015 Dec;103(12):3993-4023. doi: 10.1002/jbm.a.35515. Epub 2015 Aug 14. J Biomed Mater Res A. 2015. PMID: 26034007 Review.
Cited by
-
Telomere dynamics and homeostasis in a transmissible cancer.PLoS One. 2012;7(8):e44085. doi: 10.1371/journal.pone.0044085. Epub 2012 Aug 29. PLoS One. 2012. PMID: 22952882 Free PMC article.
-
Telomerase-mediated lifespan extension of human bronchial cells does not affect hexavalent chromium-induced cytotoxicity or genotoxicity.Mol Cell Biochem. 2004 Jan;255(1-2):103-11. doi: 10.1023/b:mcbi.0000007266.82705.d9. Mol Cell Biochem. 2004. PMID: 14971651
-
The intrabody targeting of hTERT attenuates the immortality of cancer cells.Cell Mol Biol Lett. 2010;15(1):32-45. doi: 10.2478/s11658-009-0032-2. Epub 2009 Sep 23. Cell Mol Biol Lett. 2010. PMID: 19774346 Free PMC article.
-
The telomere length dynamic and methods of its assessment.J Cell Mol Med. 2005 Oct-Dec;9(4):977-89. doi: 10.1111/j.1582-4934.2005.tb00395.x. J Cell Mol Med. 2005. PMID: 16364206 Free PMC article. Review.
-
Dynamic proteomics reveals bimodal protein dynamics of cancer cells in response to HSP90 inhibitor.BMC Syst Biol. 2017 Mar 7;11(1):33. doi: 10.1186/s12918-017-0410-8. BMC Syst Biol. 2017. PMID: 28270142 Free PMC article.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources